A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
GlaxoSmithKline
K36 Therapeutics, Inc.
Rondo Therapeutics
Dragonfly Therapeutics
Atavistik Bio, Inc
Merck Sharp & Dohme LLC
Alterome Therapeutics, Inc.
Nuvectis Pharma, Inc.
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Janssen Research & Development, LLC
Angiex, Inc.
Werewolf Therapeutics, Inc.
Adaptimmune
Bristol-Myers Squibb
Novartis
OncoNano Medicine, Inc.
Calico Life Sciences LLC
Celgene
Sairopa B.V.
Bristol-Myers Squibb
Degron Therapeutics Co.
AstraZeneca
Coherus Oncology, Inc.
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
Nurix Therapeutics, Inc.
Kazia Therapeutics Limited
Pfizer
Exelixis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Trishula Therapeutics, Inc.
Peking University First Hospital
Trishula Therapeutics, Inc.
DEKA Biosciences
Advanced Accelerator Applications
Revolution Medicines, Inc.
Endocyte
LaunXP Biomedical Co., Ltd.
GlaxoSmithKline
The Netherlands Cancer Institute
Poseida Therapeutics, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc